FWCM
BIIB icon

Ferguson Wellman Capital Management’s Biogen BIIB Stock Holding History

Ferguson Wellman Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,275
Closed -$330K – 371
2023
Q4 		$330K Sell
1,275
-4
-0.3% -$982 0.01% 294
2023
Q3 		$329K Buy
1,279
+4
+0.3% +$1.07K 0.01% 284
2023
Q2 		$363K Hold
1,275
– – 0.01% 279
2023
Q1 		$354K Sell
1,275
-12
-0.9% -$3.32K 0.01% 285
2022
Q4 		$356K Hold
1,287
– – 0.01% 280
2022
Q3 		$344K Buy
1,287
+13
+1% +$2.76K 0.01% 251
2022
Q2 		$260K Hold
1,274
– – 0.01% 286
2022
Q1 		$268K Buy
+1,274
New +$277K 0.01% 297
2019
Q2 		– Sell
-1,044
Closed -$247K – 334
2019
Q1 		$247K Sell
1,044
-2,376
-69% -$748K 0.01% 313
2018
Q4 		$1.03M Sell
3,420
-40,864
-92% -$13M 0.04% 203
2018
Q3 		$15.6M Sell
44,284
-33,889
-43% -$11.7M 0.51% 51
2018
Q2 		$22.7M Sell
78,173
-715
-0.9% -$201K 0.79% 38
2018
Q1 		$21.6M Buy
78,888
+174
+0.2% +$54K 0.77% 36
2017
Q4 		$25.1M Sell
78,714
-130
-0.2% -$41.7K 0.87% 33
2017
Q3 		$24.7M Sell
78,844
-586
-0.7% -$174K 0.89% 34
2017
Q2 		$21.6M Buy
79,430
+1,838
+2% +$486K 0.81% 43
2017
Q1 		$21.2M Buy
77,592
+40,869
+111% +$11.6M 0.82% 41
2016
Q4 		$10.4M Buy
36,723
+35,845
+4,083% +$10.6M 0.42% 70
2016
Q3 		$275K Hold
878
– – 0.01% 271
2016
Q2 		$212K Hold
878
– – 0.01% 305
2016
Q1 		$229K Hold
878
– – 0.01% 285
2015
Q4 		$269K Buy
+878
New +$252K 0.01% 287
2015
Q3 		– Sell
-503
Closed -$203K – 311
2015
Q2 		$203K Hold
503
– – 0.01% 315
2015
Q1 		$212K Buy
+503
New +$198K 0.01% 312
2014
Q1 		– Sell
-1,355
Closed -$379K – 312
2013
Q4 		$379K Sell
1,355
-420
-24% -$109K 0.02% 251
2013
Q3 		$427K Sell
1,775
-41,035
-96% -$9.18M 0.02% 225
2013
Q2 		$9.21M Buy
+42,810
New +$9.15M 0.71% 54

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ferguson Wellman Capital Management's BIIB Position: Q1 2024 in Review

Ferguson Wellman Capital Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,275 shares — an estimated $330K sold.

Ferguson Wellman Capital Management first reported a position in BIIB in Q2 2013 and held it in 27 quarters. The position peaked at $25.1M in Q4 2017. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Ferguson Wellman Capital Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Ferguson Wellman Capital Management sold 1,275 Biogen shares in Q1 2024, an estimated $330K.
  • Ferguson Wellman Capital Management first reported a position in Biogen in Q2 2013 and held it in 27 quarters.
  • Ferguson Wellman Capital Management's Biogen position peaked at $25.1M in Q4 2017.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Ferguson Wellman Capital Management's 13F filing for Q1 2024, filed 9 Apr 2024.